Literature DB >> 25466255

Activation of toll-like receptor-2 by endogenous matrix metalloproteinase-2 modulates dendritic-cell-mediated inflammatory responses.

Emmanuelle Godefroy1, Anne Gallois1, Juliana Idoyaga2, Miriam Merad1, Navpreet Tung1, Ngozi Monu3, Yvonne Saenger1, Yichun Fu1, Rajesh Ravindran4, Bali Pulendran4, Francine Jotereau5, Sergio Trombetta3, Nina Bhardwaj6.   

Abstract

Matrix metalloproteinase-2 (MMP-2) is involved in several physiological mechanisms, including wound healing and tumor progression. We show that MMP-2 directly stimulates dendritic cells (DCs) to both upregulate OX40L on the cell surface and secrete inflammatory cytokines. The mechanism underlying DC activation includes physical association with Toll-like receptor-2 (TLR2), leading to NF-κB activation, OX40L upregulation on DCs, and ensuing TH2 differentiation. Significantly, MMP-2 polarizes T cells toward type 2 responses in vivo, in a TLR2-dependent manner. MMP-2-dependent type 2 polarization may represent a key immune regulatory mechanism for protection against a broad array of disorders, such as inflammatory, infectious, and autoimmune diseases, which can be hijacked by tumors to evade immunity.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25466255      PMCID: PMC4336179          DOI: 10.1016/j.celrep.2014.10.067

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  67 in total

Review 1.  Regulation of matrix metalloproteinase expression in tumor invasion.

Authors:  J Westermarck; V M Kähäri
Journal:  FASEB J       Date:  1999-05       Impact factor: 5.191

2.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

3.  Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter.

Authors:  J Bian; Y Sun
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  TLR2 recognizes a bacterial lipopeptide through direct binding.

Authors:  Thierry Vasselon; Patricia A Detmers; Dominique Charron; Alain Haziot
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

5.  Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88.

Authors:  Uzma Hasan; Claire Chaffois; Claude Gaillard; Virginie Saulnier; Estelle Merck; Sandra Tancredi; Chantal Guiet; Francine Brière; Jaromir Vlach; Serge Lebecque; Giorgio Trinchieri; Elizabeth E M Bates
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

6.  Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.

Authors:  P C Brooks; S Silletti; T L von Schalscha; M Friedlander; D A Cheresh
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

7.  CD36 is a sensor of diacylglycerides.

Authors:  Kasper Hoebe; Philippe Georgel; Sophie Rutschmann; Xin Du; Suzanne Mudd; Karine Crozat; Sosathya Sovath; Louis Shamel; Thomas Hartung; Ulrich Zähringer; Bruce Beutler
Journal:  Nature       Date:  2005-02-03       Impact factor: 49.962

8.  Non-proteolytic, receptor/ligand interactions associate cellular membrane type-1 matrix metalloproteinase with the complement component C1q.

Authors:  Dmitri V Rozanov; Sergey Sikora; Adam Godzik; Tatiana I Postnova; Vladislav Golubkov; Alexei Savinov; Stephen Tomlinson; Alex Y Strongin
Journal:  J Biol Chem       Date:  2004-09-16       Impact factor: 5.157

9.  A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.

Authors:  Hagen Kulbe; Probir Chakravarty; D Andrew Leinster; Kellie A Charles; Joseph Kwong; Richard G Thompson; Jermaine I Coward; Tiziana Schioppa; Stephen C Robinson; William M Gallagher; Laura Galletta; Michael A Salako; John F Smyth; Thorsten Hagemann; Donal J Brennan; David D Bowtell; Frances R Balkwill
Journal:  Cancer Res       Date:  2011-11-07       Impact factor: 12.701

10.  alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen.

Authors:  Emmanuelle Godefroy; Agnes Moreau-Aubry; Elisabeth Diez; Brigitte Dreno; Francine Jotereau; Yannick Guilloux
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

View more
  20 in total

1.  RNA-Binding Protein HuR Regulates Paneth Cell Function by Altering Membrane Localization of TLR2 via Post-transcriptional Control of CNPY3.

Authors:  Lan Xiao; Xiao-Xue Li; Hee Kyoung Chung; Sudhakar Kalakonda; Jia-Zhong Cai; Shan Cao; Ning Chen; Yulan Liu; Jaladanki N Rao; Hong-Ying Wang; Myriam Gorospe; Jian-Ying Wang
Journal:  Gastroenterology       Date:  2019-05-17       Impact factor: 22.682

2.  Special Conference on Tumor Immunology and Immunotherapy: A New Chapter.

Authors:  Katelyn T Byrne; Robert H Vonderheide; Elizabeth M Jaffee; Todd D Armstrong
Journal:  Cancer Immunol Res       Date:  2015-05-12       Impact factor: 11.151

Review 3.  Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.

Authors:  Fotis Asimakopoulos; Chelsea Hope; Michael G Johnson; Adam Pagenkopf; Kimberly Gromek; Bradley Nagel
Journal:  J Leukoc Biol       Date:  2017-03-02       Impact factor: 4.962

Review 4.  Modulation of innate immunity in the tumor microenvironment.

Authors:  Elena Gonzalez-Gugel; Mansi Saxena; Nina Bhardwaj
Journal:  Cancer Immunol Immunother       Date:  2016-06-25       Impact factor: 6.968

Review 5.  Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment.

Authors:  Mansi Saxena; Nina Bhardwaj
Journal:  Trends Cancer       Date:  2018-02

Review 6.  Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical Trials.

Authors:  Fengqian Chen; Lin Zou; Brittney Williams; Wei Chao
Journal:  Antioxid Redox Signal       Date:  2021-04-07       Impact factor: 8.401

7.  SIRT6 protects against endothelial dysfunction and atherosclerosis in mice.

Authors:  Suowen Xu; Meimei Yin; Marina Koroleva; Michael A Mastrangelo; Wenbo Zhang; Peter Bai; Peter J Little; Zheng Gen Jin
Journal:  Aging (Albany NY)       Date:  2016-05       Impact factor: 5.682

8.  CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy.

Authors:  Lena M Kranz; Matthias Birtel; Christina Krienke; Christian Grunwitz; Jutta Petschenka; Kerstin C Reuter; Niels van de Roemer; Fulvia Vascotto; Mathias Vormehr; Sebastian Kreiter; Mustafa Diken
Journal:  Hum Vaccin Immunother       Date:  2015-07-17       Impact factor: 3.452

9.  Rap1-mediated nuclear factor-kappaB (NF-κB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarction.

Authors:  Y Zhang; S Chiu; X Liang; F Gao; Z Zhang; S Liao; Y Liang; Y-H Chai; D J H Low; H-F Tse; V Tergaonkar; Q Lian
Journal:  Cell Death Discov       Date:  2015-08-24

10.  MMP2 and TLRs modulate immune responses in the tumor microenvironment.

Authors:  Luciana R Muniz-Bongers; Christopher B McClain; Mansi Saxena; Gerold Bongers; Miriam Merad; Nina Bhardwaj
Journal:  JCI Insight       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.